Mutant KRAS promotes malignant pleural effusion formation
Malignant pleural effusion (MPE) is a lethal condition associated with various cancers. Here, the authors show that cancer cells withKRASmutations promote MPE by recruiting myeloid cells via CCL2 signalling and that pharmaceutical targeting of KRAS results in reduced MPE incidence and volume in mous...
Guardado en:
Autores principales: | Theodora Agalioti, Anastasios D. Giannou, Anthi C. Krontira, Nikolaos I. Kanellakis, Danai Kati, Malamati Vreka, Mario Pepe, Magda Spella, Ioannis Lilis, Dimitra E. Zazara, Eirini Nikolouli, Nikolitsa Spiropoulou, Andreas Papadakis, Konstantina Papadia, Apostolos Voulgaridis, Vaggelis Harokopos, Panagiota Stamou, Silke Meiners, Oliver Eickelberg, Linda A. Snyder, Sophia G. Antimisiaris, Dimitrios Kardamakis, Ioannis Psallidas, Antonia Marazioti, Georgios T. Stathopoulos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0a878d637c6749f7a229ddbc89117bed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion
por: Antonia Marazioti, et al.
Publicado: (2018) -
Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection
por: Marazioti A, et al.
Publicado: (2019) -
Metabolic Disorders in Multiple Myeloma
por: Maria Gavriatopoulou, et al.
Publicado: (2021) -
Theresa Hak Kyung Cha, Dictée
por: Caterina Stamou
Publicado: (2019) -
4-(Indol-3-yl)thiazole-2-amines and 4-ιndol-3-yl)thiazole Acylamines as Νovel Antimicrobial Agents: Synthesis, In Silico and In Vitro Evaluation
por: Sergei Simakov, et al.
Publicado: (2021)